Gene expression profiling of parkinsonian substantia nigra pars compacta;: alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes

被引:277
作者
Grünblatt, E
Mandel, S
Jacob-Hirsch, J
Zeligson, S
Amariglo, N
Rechavi, G
Li, J
Ravid, R
Roggendorf, W
Riederer, P
Youdim, MBH
机构
[1] Univ Wurzburg, Inst Clin Neurochem, D-97070 Wurzburg, Germany
[2] Univ Wurzburg, Natl Parkinson Fdn Ctr Excellence Labs, Clin & Policlin Psychiat & Psychotherapy, D-97070 Wurzburg, Germany
[3] Technion Israel Inst Technol, Rappaport Family Fac Med, Eve Topf & US Natl Parkinson Fdn Ctr Excellence, Haifa, Israel
[4] Chaim Sheba Med Ctr, Inst Hematol, Funct Genom Unit, Tel Aviv, Israel
[5] Netherlands Brain Bank, Amsterdam, Netherlands
[6] Univ Wurzburg, Inst Pathol, Dept Neuropathol, D-97070 Wurzburg, Germany
关键词
affymetrix; Parkinson's disease; substantia nigra pars compacta; cerebellum; gene expression; quantitative real-time PCR; ubiquitin-proteasome system; SKP1A; HSC70; iron;
D O I
10.1007/s00702-004-0212-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Gene expression profiling of human substantia nigra pars compacta (SNpc) from Parkinson's disease (PD) patients, was examined employing high density microarrays. We identified alterations in the expression of 137 genes, with 68 down regulated and 69 up regulated. The down regulated genes belong to signal transduction, protein degradation (e.g. ubiquitin-proteasome subunits), dopaminergic transmission/metabolism, ion transport, protein modification/phosphorylation and energy pathways/glycolysis functional classes. Up-regulated genes, clustered mainly in biological processes involving cell adhesion/cytoskeleton, extracellular matrix components, cell cycle, protein modification/phosphorylation, protein metabolism, transcription and inflammation/stress (e.g. key iron and oxygen sensor EGLN1). One major finding in the present study is the particular decreased expression of SKP1A, a member of the SCF (E3) ligase complex specifically in the substantia nigra (SN) of sporadic parkinsonian patients, which may lead to a wide impairment in the function of an entire repertoire of proteins subjected to regulatory ubiquitination. These findings reveal novel players in the neurodegenerative scenario and provide potential targets for the development of novel drug compounds.
引用
收藏
页码:1543 / 1573
页数:31
相关论文
共 91 条
[1]   MONOAMINE-OXIDASE AND ALDEHYDE DEHYDROGENASE-ACTIVITY IN STRIATUM OF RATS AFTER 6-HYDROXYDOPAMINE LESION OF NIGROSTRIATAL PATHWAY [J].
AGID, Y ;
JAVOY, F ;
YOUDIM, MBH .
BRITISH JOURNAL OF PHARMACOLOGY, 1973, 48 (01) :175-178
[2]   Chaperone suppression of α-synuclein toxicity in a Drosophila model for Parkinson's disease [J].
Auluck, PK ;
Chan, HYE ;
Trojanowski, JQ ;
Lee, VMY ;
Bonini, NM .
SCIENCE, 2002, 295 (5556) :865-868
[3]   Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [18F]FDG-PET [J].
Berding, G ;
Odin, P ;
Brooks, DJ ;
Nikkhah, G ;
Matthies, C ;
Peschel, T ;
Shing, M ;
Kolbe, H ;
van den Hoff, J ;
Fricke, H ;
Dengler, R ;
Samii, M ;
Knapp, WH .
MOVEMENT DISORDERS, 2001, 16 (06) :1014-1022
[4]   The SRm160/300 splicing coactivator subunits [J].
Blencowe, BJ ;
Baurén, G ;
Eldridge, AG ;
Issner, R ;
Nickerson, JA ;
Rosonina, E ;
Sharp, PA .
RNA, 2000, 6 (01) :111-120
[5]   Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism [J].
Bonifati, V ;
Rizzu, P ;
van Baren, MJ ;
Schaap, O ;
Breedveld, GJ ;
Krieger, E ;
Dekker, MCJ ;
Squitieri, F ;
Ibanez, P ;
Joosse, M ;
van Dongen, JW ;
Vanacore, N ;
van Swieten, JC ;
Brice, A ;
Meco, G ;
van Duijn, CM ;
Oostra, BA ;
Heutink, P .
SCIENCE, 2003, 299 (5604) :256-259
[6]   Chaperoning brain degeneration [J].
Bonini, NM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 :16407-16411
[7]   Diagnostic criteria for neuropathologic assessment of Alzheimer's disease [J].
Braak, H ;
Braak, E .
NEUROBIOLOGY OF AGING, 1997, 18 (04) :S85-S88
[8]   Imaging end points for monitoring neuroprotection in Parkinson's disease [J].
Brooks, DJ .
ANNALS OF NEUROLOGY, 2003, 53 :S110-S118
[9]   The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg [J].
Ciechanover, A ;
Brundin, P .
NEURON, 2003, 40 (02) :427-446
[10]   Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from α-synuclein in vitro [J].
Cohlberg, JA ;
Li, J ;
Uversky, VN ;
Fink, AL .
BIOCHEMISTRY, 2002, 41 (05) :1502-1511